Edesa CEO awarded 1,159 RSUs, updates holdings
Nijhawan Pardeep reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Nijhawan Pardeep reported acquisition or exercise transactions in this Form 4 filing.
Edesa Biotech, Inc. director and Chief Executive Officer Pardeep Nijhawan reported an equity award and updated share holdings. He received a grant of 1,159 restricted share units that vested in full upon grant at a price of $0.0000 per share under the company’s 2019 Equity Incentive Compensation Plan, increasing his direct holdings to 632,550 common shares following the award.
Indirect holdings are reported through several entities: 402,702 common shares held by Pardeep Nijhawan Medicine Professional Corporation, 53,104 shares held by 1968160 Ontario Inc., 32,013 shares held by The Digestive Health Clinic Inc., and 32,609 shares held by The New Nijhawan Family Trust 2015. The reporting person disclaims beneficial ownership of these indirect securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,159 shares
Grant/Award
5 txns
Insider
Nijhawan Pardeep
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 1,159 | $0.00 | $0.00 |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
| holding | Common Shares | -- | -- | -- |
Holdings After Transaction:
Common Shares — 632,550 shares (Direct);
Common Shares — 402,702 shares (Indirect, Held by Pardeep Nijhawan Medicine Professional Corporation);
Common Shares — 32,609 shares (Indirect, Held by The New Nijhawan Family Trust 2015);
Common Shares — 32,013 shares (Indirect, Held by The Digestive Health Clinic Inc.);
Common Shares — 53,104 shares (Indirect, Held by 1968160Ontario Inc.)
Footnotes (3)
- F1. Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
- F2. Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3. Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
RSU grant: 1,159 common shares
Direct holdings after grant: 632,550 common shares
Indirect holdings (Medicine Corp.): 402,702 common shares
+4 more
7 metrics
RSU grant
1,159 common shares
Restricted share units vested in full upon grant at $0.0000 per share
Direct holdings after grant
632,550 common shares
Shares directly held by reporting person following RSU award
Indirect holdings (Medicine Corp.)
402,702 common shares
Held by Pardeep Nijhawan Medicine Professional Corporation
Indirect holdings (1968160 Ontario Inc.)
53,104 common shares
Held by 1968160 Ontario Inc.
Indirect holdings (Digestive Health Clinic)
32,013 common shares
Held by The Digestive Health Clinic Inc.
Indirect holdings (Family Trust)
32,609 common shares
Held by The New Nijhawan Family Trust 2015
Grant price per share
$0.0000 per share
Price for restricted share units granted under 2019 plan
Key Terms
restricted share units, 2019 Equity Incentive Compensation Plan, pecuniary interest, beneficial ownership, +2 more
6 terms
2019 Equity Incentive Compensation Plan financial
"vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan"
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein"
beneficial ownership financial
"shall not be deemed an admission of beneficial ownership of all of the reported shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
co-trustee financial
"Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015"
Section 16 regulatory
"for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Edesa Biotech (EDSA) CEO Pardeep Nijhawan report in this Form 4?
He reported an equity compensation award and updated share holdings. The filing shows a grant of 1,159 restricted share units and updated direct and indirect ownership positions across several related entities and a family trust.
AI-generated analysis. How Rhea-AI works. Not financial advice.
